{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T12:40:48Z","timestamp":1761741648864,"version":"build-2065373602"},"reference-count":26,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2011,8,1]],"date-time":"2011-08-01T00:00:00Z","timestamp":1312156800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,8,1]],"date-time":"2011-08-01T00:00:00Z","timestamp":1312156800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2011,8,30]],"date-time":"2011-08-30T00:00:00Z","timestamp":1314662400000},"content-version":"vor","delay-in-days":29,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/3.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics"],"published-print":{"date-parts":[[2011,8]]},"DOI":"10.1590\/s1807-59322011000800023","type":"journal-article","created":{"date-parts":[[2011,9,8]],"date-time":"2011-09-08T14:34:48Z","timestamp":1315492488000},"page":"1443-1449","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["The effect of subconjunctival bevacizumab on corneal neovascularization, inflammation and re-epithelization in a rabbit model"],"prefix":"10.1016","volume":"66","author":[{"given":"Glauco Reggiani","family":"Mello","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcos Longo","family":"Pizzolatti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Wasilewski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcony R.","family":"Santhiago","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vin\u00edcius","family":"Budel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hamilton","family":"Moreira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1590\/S1807-59322011000800023_bib1","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1097\/00055735-200108000-00002","article-title":"Corneal neovascularization","volume":"12","author":"Chang","year":"2001","journal-title":"Curr Opin Ophthalmol"},{"key":"10.1590\/S1807-59322011000800023_bib2","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1097\/00007890-198807000-00003","article-title":"An animal model for corneal graft rejection in high-risk keratoplasty","volume":"46","author":"Hill","year":"1988","journal-title":"Transplantation"},{"key":"10.1590\/S1807-59322011000800023_bib3","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1097\/01.ico.0000138841.44926.f8","article-title":"Opinions on risk factors and management of corneal graft rejection in the United kingdom","volume":"24","author":"Koay","year":"2005","journal-title":"Cornea"},{"key":"10.1590\/S1807-59322011000800023_bib4","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1034\/j.1600-0420.2002.800102.x","article-title":"Emergency treatment of chemical and thermal eye burns","volume":"80","author":"Kuckelkorn","year":"2002","journal-title":"Acta Ophthalmol Scand"},{"key":"10.1590\/S1807-59322011000800023_bib5","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1111\/j.1600-0420.2006.00659.x","article-title":"Ocular angiogenesis: the role of growth factors","volume":"84","author":"Kvanta","year":"2006","journal-title":"Acta Ophthalmol Scand"},{"key":"10.1590\/S1807-59322011000800023_bib6","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.ajo.2007.11.003","article-title":"Inhibition of corneal neovascularization by subconjunctival bevacizumab in an animal model","volume":"145","author":"Papathanassiou","year":"2008","journal-title":"Am J Ophthalmol"},{"key":"10.1590\/S1807-59322011000800023_bib7","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1001\/archopht.1996.01100140172010","article-title":"Vascular endothelial growth factor is sufficient to produce iris neovascularization and neovascular glaucoma in a nonhuman primate","volume":"114","author":"Tolentino","year":"1996","journal-title":"Arch Ophthalmol"},{"key":"10.1590\/S1807-59322011000800023_bib8","first-page":"2514","article-title":"Expression of vascular endothelial growth factor and its receptors in inflamed and vascularized human corneas","volume":"41","author":"Philipp","year":"2000","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1590\/S1807-59322011000800023_bib9","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1111\/j.1600-0420.2004.00312.x","article-title":"Vascular endothelial growth factor (VEGF) and its receptor VEGFR-2 in the regulation of corneal neovascularization and wound healing","volume":"82","author":"Gan","year":"2004","journal-title":"Acta Ophthalmol Scand"},{"key":"10.1590\/S1807-59322011000800023_bib10","first-page":"47","article-title":"Anti-VEGF Therapy: Next Stop, Glaucoma","volume":"15","author":"Kahook","year":"2008","journal-title":"Review of Ophthalmology"},{"key":"10.1590\/S1807-59322011000800023_bib11","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1016\/j.ophtha.2008.04.023","article-title":"Vitreous levels of bevacizumab and vascular endothelial growth factor-A in patients with choroidal neovascularization","volume":"115","author":"Zhu","year":"2008","journal-title":"Ophthalmology"},{"key":"10.1590\/S1807-59322011000800023_bib12","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1111\/j.1442-9071.2007.01572.x","article-title":"Bevacizumab inhibits corneal neovascularization in an alkali burn induced model of corneal angiogenesis","volume":"35","author":"Hosseini","year":"2007","journal-title":"Clin Experiment Ophthalmol"},{"key":"10.1590\/S1807-59322011000800023_bib13","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1097\/ICO.0b013e318160d019","article-title":"Effect of subconjunctival bevacizumab (Avastin) on experimental corneal neovascularization in guinea pigs","volume":"27","author":"Hurmeric","year":"2008","journal-title":"Cornea"},{"key":"10.1590\/S1807-59322011000800023_bib14","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1590\/S0102-86502005000100010","article-title":"Modelo de angiog\u00eanese inflamat\u00f3ria em c\u00f3rnea de coelho induzida pela cauteriza\u00e7\u00e3o alcalina pontual","volume":"20","author":"Fechine-Jamacaru","year":"2005","journal-title":"Acta Cir. bras"},{"key":"10.1590\/S1807-59322011000800023_bib15","doi-asserted-by":"crossref","first-page":"5217","DOI":"10.1167\/iovs.08-2662","article-title":"Inhibition of vascular endothelial growth factor reduces scar formation after glaucoma filtration surgery","volume":"50","author":"Li","year":"2009","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1590\/S1807-59322011000800023_bib16","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1111\/j.1600-0420.2007.01049.x","article-title":"Safety, penetration and efficacy of topically applied bevacizumab: evaluation of eyedrops in corneal neovascularization after chemical burn","volume":"86","author":"Yoeruek","year":"2008","journal-title":"Acta Ophthalmol"},{"key":"10.1590\/S1807-59322011000800023_bib17","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1007\/s00417-009-1101-y","article-title":"Anti-VEGF monoclonal antibody-induced regression of corneal neovascularization and inflammation in a rabbit model of herpetic stromal keratitis","volume":"247","author":"Saravia","year":"2009","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1590\/S1807-59322011000800023_bib18","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s10456-007-9063-3","article-title":"Effects of topical administration of 12-methyl tetradecanoic acid (12-MTA) on the development of corneal angiogenesis","volume":"10","author":"Cole","year":"2007","journal-title":"Angiogenesis"},{"key":"10.1590\/S1807-59322011000800023_bib19","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/s00417-007-0684-4","article-title":"Bevacizumab (Avastin) eye drops inhibit corneal neovascularization","volume":"246","author":"Bock","year":"2008","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1590\/S1807-59322011000800023_bib20","doi-asserted-by":"crossref","first-page":"4653","DOI":"10.1167\/iovs.08-2805","article-title":"Bevacizumab application delays epithelial healing in rabbit cornea","volume":"50","author":"Kim","year":"2009","journal-title":"Investigative ophthalmology & visual science"},{"key":"10.1590\/S1807-59322011000800023_bib21","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1097\/ICO.0b013e31818b8be0","article-title":"Evaluation of cytotoxic effects of bevacizumab on human corneal cells","volume":"28","author":"Chalam","year":"2009","journal-title":"Cornea"},{"key":"10.1590\/S1807-59322011000800023_bib22","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1097\/ICO.0b013e3181b1c82f","article-title":"The effect of subconjuctival combined treatment of bevacizumab and triamcinolone acetonide on corneal neovascularization in rabbits","volume":"29","author":"Kang","year":"2010","journal-title":"Cornea"},{"key":"10.1590\/S1807-59322011000800023_bib23","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1111\/j.1442-9071.2010.02252.x","article-title":"Inhibition of corneal neovascularization after alkali burn: comparison of different doses of bevacizumab in monotherapy or associated with dexamethasone","volume":"38","author":"Hoffart","year":"2010","journal-title":"Clinical & experimental ophthalmology"},{"key":"10.1590\/S1807-59322011000800023_bib24","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1097\/ICO.0b013e3181ae91e3","article-title":"The effect of subconjunctival suramin on corneal neovascularization in rabbits","volume":"29","author":"Lee","year":"2010","journal-title":"Cornea"},{"key":"10.1590\/S1807-59322011000800023_bib25","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.ajo.2010.04.024","article-title":"Inhibition of Corneal Neovascularization by Topical Bevacizumab (Anti-VEGF) and Sunitinib (Anti-VEGF and Anti-PDGF) in an Animal Model","volume":"150","author":"P\u00e9rez-Santonja","year":"2010","journal-title":"Am J ophthalmol"},{"key":"10.1590\/S1807-59322011000800023_bib26","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/j.ajo.2007.06.039","article-title":"Anti-VEGF agents in the treatment of neovascular age-related macular degeneration: applying clinical trial results to the treatment of everyday patients","volume":"144","author":"Brown","year":"2007","journal-title":"Am J Ophthalmol"}],"container-title":["Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S180759322201986X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S180759322201986X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.scielo.br\/pdf\/clin\/v66n8\/23.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T07:08:07Z","timestamp":1761721687000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S180759322201986X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,8]]},"references-count":26,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2011,8]]}},"alternative-id":["S180759322201986X"],"URL":"https:\/\/doi.org\/10.1590\/s1807-59322011000800023","relation":{},"ISSN":["1807-5932"],"issn-type":[{"type":"print","value":"1807-5932"}],"subject":[],"published":{"date-parts":[[2011,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The effect of subconjunctival bevacizumab on corneal neovascularization, inflammation and re-epithelization in a rabbit model","name":"articletitle","label":"Article Title"},{"value":"Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1590\/S1807-59322011000800023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 CLINICS. Published by Elsevier Spain","name":"copyright","label":"Copyright"}]}}